The petition aimed to combat conflicts of interest within the German authorities and to promote independent risk research
17 December 2014 The petition was started in 2013 by a broad coalition of organisations. It aimed to combat conflict of interests within German authorities and to strengthen industry-independent risk research, especially in context of biotechnology. Testbiotech has now been informed that the committee for petitions in the German parliament has recommended rejecting the initiative.
Concerns about feeding study with genetically engineered maize still urgent
15 December 2014 / Testbiotech has sent a letter to EU Commissioner Vytenis Andriukaitis re-stating its criticism of the Zeljenkova et al. (2014) publication on the outcome of a feeding trial with rats, conducted under the GRACE project funded by the EU Commission. The rats were fed over a period of 90 days with genetically engineered maize MON810, which produces an insecticidal protein, and the results were published in October 2014 in the journal Archives of Toxicology. Testbiotech is requesting that this publication be withdrawn for the following reasons:
Testbiotech sends open letter to German government
25. November 2014 / A final vote on the authorisation for the import of the genetically engineered oilseed rape produced by Monsanto (MON88302) has been scheduled for 28 November. The German government abstained in the first round of voting. If no majority is reached in this final vote it will be up to the EU Commission to make a decision. If authorised, the glyphosate-resistant plants will be imported as viable seeds and, in Europe, processed into feed.
In a letter to the new EU-Commissioner Testbiotech demands access to further data
Tuesday, 18 November 2014
The EU project GRACE, has published a first response to Testbiotech’s exposure of flaws in a rat feeding study with genetically engineered maize. In an open letter to Testbiotech, Joachim Schiemann, coordinator of the GRACE Consortium, rejected the objections raised by Testbiotech. At the same time, he neither rebutted Testbiotech’s critique nor did he address the network of vested interests around the publication. In regard to the toxicological data, he mostly repeated what was already stated in the study and therefore criticised by Testbiotech.
English
Deutsch
